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n&O (c. pncumor~?e) causes coronary artery d~seasu. There are saverat 
reports that Ihe argantrm IR found m diseased but no1 normal coronary ar. 
lanes. For the hrs;l time. wo have studied whole segments of diseased and 
norm%1 blood vesnets (mm IN0 paltents 
Method’ From 38 paltonls undergoing redo and 9 patients undergoing 
lust bmo cotonety artery byp%es graft aurgmy. tntmls ot occluded venous 
graft% Of %lh%f@&tny Ot tl%tiv% rZoRXl%rY veS%el% were obtained along with 
eegments ot nonni?l saphenous vem and int%m%l tnammmy arteery (IMA) G. 
pneumon& DNA w%% ctwcked tot by tC @ytnof%8% chain m%ctkm (PCR) 
conctusKrm c mae is unfikety to ke a direr3 cause of athefoacfe- 
fosrs as tt 1s kxmcl Ihra@o@ the ~scdar k?e fncfcadmg fhe IMA whrch IS not 
assoccated wtth a!heroecterosis. Nowever. we have not ruled oul an tndx%ct 
el?ect such as increasmg the cwagulalnlty of b!ood ur mat It ex,acecbates 
Pm-eXlstmq ptaques 
lzzl 1064 9 Risk Factors in +TMm Populations at ContrastIng 
Risk for Coronary Amy Diise 
J. Fetires. A. Evans. P. Anxxiyel. D. Awetler, J. Yamell. J 8. Awdaveb. 
I-J. Vague. J.C. Fruchart. G. Luc. PY. Scarabm. F Cambten, P Ducrmetlere. 
Cam De@Tmenl CtfU Purpan. fb&use. France 
Backgruuncf. The mctdence ot coronary artery disease (CAD) m m&lbagea 
men IS more than three bees higner m Not-Wrn Ireland than m France. The 
PRIME Stu@y, based on WHO MONICA Centers in Belfast (Northern treland, 
2748 men), U!te (Nonhem France. 2627 men). Strasbourg (Eastem France. 
2611 men) andToutousa(Sauthwestem France, 261Omen). rsacohortstudy 
m which we pian to analyze the m+tirtco of CAD nsk factors m men aged 
4S-KI years over a penod ot 5 years 
Meethcds: We compared the nsk factor level between 451 CAD subfects 
(prewous myocardial mtarchon or angma) al entry and 10145 &as&me 
subtects Ctkxcal variable-s (age. body mass index. b&d pressure. cigarette 
smokmg. diabetes melktus. alconol consumptron). fibrinogen levels and an 
u+&plh SALK& 01 l~pcl vanables [total cholesterol. tnglycende. HDL choles- 
terol, apokpopmtem (ape) At, apo 8, kpoprotem parttcle (Lp) Al. Lpa (a) Lp 
BE) were analyzed m this p:t?valence case-conrrol study 
ResurSr After aqustement for age. body mass index. blood pressure level. 
crgarette smokmg. dtab-etes and alcohol consumption. m Norlhem Ireland and 
France, patients m comparison wtth controls (p _ 0.01) had lower levels of 
HDL cholesterol. apo Al. Lp At and hrgher levels 01 fibrinogen. mgfY.Xride. 
apo 8. Lp BE and Lp (a). In two countnes wrth stnkmg dtfferences In CAD 
nsk. differences between cases and contmls were srmllar. However. Lp (a). 
Lp 6:E and fibrinogen levels were htgher and Lp Al levels were tower m 
Northern lnsh than tn French contmls (p q 0.001). 
Cotiusron: These results could explam part of the larp excess of CAD 
observed m Northern Ireland and the prospectwe pan of Ihe study will permet 
to quanttfy 11. 
\1064-10 ] Enhanced Expression of Endothelin-Converting 
Enzyme Is Associated With the Pmgression of 
Coronary Aiherosclemsis in Humans 
Takahiko Naruko. Makiko Ueda. Kazuo Haze. Allard C. van der Wal. Chris 
M. van der Loos. Kazuhlko Tanzawa. Antol, E. Becker. O&a Cify Genera/ 
Hospffal. Osaka. Japan; Academic Med;ca/ Center. Amsterdam. The 
NerheCnds 
Background: Endolhelin-1 is a potent vasoconslrictor and presents a mlto- 
genie ac’ vity on vascular smoath muscle cells (SMC). Endothelmconvertmg 
e.?:yme (ECE) is the final key enzyme al endathelin-1 processing. We stud- 
ied the expression of ECE in human coronary athemsclemlrc lestons. using 
immunoc@chemical techniques. 
Methods: Fmzen sections. normal with diffuse intimal thickening (DIT; n 
= 23). and diseased, with early alherosclemtlc plaques (early AP: n = 6). 
and advanced atherosclerotic plaques (advanced AP: n = 18) were studied. 
Monoclonal antibodies were directed against SMC. macrophages (Ma). en- 
dothelial cells (EC), and ECE (AEC32-236). For the identification of cell types 
which express ECE, the immunodouble staining method was alS0 used. 
Moteculsr and Gfmatic Studka of uptd 
DI~ORIWQI 
MCVtelay, March 30. 1998,3:00 p.m,d:OO pm, 
(4eof9ia World Gonqress Gentar. Wea Exhibit Hall Lswl 
Preslentalian Hour: 3:OO p.m.--400 p.m. 
We haM rdenbfii 4 famtty rn New York Slate wttt mulatrons in both the 
llpoprofeln kpase (LPLJ gene and %pol@opmtam (ape) A-l gene. A -Q3TiG 
-tin n the LPL pornofor regcon was &nt&xl in 0 tamtly members. 
In addition. 2 ptewously umapocted mutations m ttw LPL promotor rem. 
~634Mand -755 G/Asegregeted withthe -93 TKi transitron mefl%tiected 
sub(ects. A bas+p%ir substiiutmn m Me apoA-I gene (Phe” - Tyr) was al%0 
rdenttfti m 12 biologtc tamiiy members. Mean levets ot Itp@s. iiins 
and apolipopmtetm m subpxts w#h the LPL vanants or ApoA-I Ptattsburgh 
(Phe” -TV) compared to unafiected family members (controls, n = 16) are 
shown m the Tabte Compared IO controls. sub@cts Wm, the LPL vanants had 
stgnrfcantty lower HDL-C (p = 0.03) and apoA-I (p = 0.03). Apia_I Platt%&urgh 
was -ated mth s&!ndrc%ntly tower HDLC (p = 0.02). The proband wnh 
%poA-I Plattsburgh (TC = 192 m$lL HDLG = 6 mg/dL. apuA-I = 24 nTg@LJ 
developed CAD at age 44 ym. Premature CAD also occumzd m assock?tion 
wlm the LPL promotor vanant. These data demonstrate that HDL-C may be 
mlluertced by more th%n one major gene candrdare wrthrn the same famdy 
and that vanants m the LPL promotor regton contribute lo low HDLG 
Mutanan TC HOL LOL TG A&MA-I AWB 
LPL 931.” 203 34 143 155 86 z- 
np0A.l 174 3i) 103 121 116 106 
COnfrOlS 199 47 128 186 127 e9 
]1065-12 Llpopmtein Lipese Gene Polymorphisms Are 
Predictors of Risk of Coronary Artery Disease 
and Myocardbl Infarclion 
J.l_ Anderson. G.J. Kmg. S.P. Elmer. T.L Barr. J.B Muhlestein. 
J.F. Carlquiet. LDS Hosprfal. Unrvem~ly of Utah S%/I Lake C@! Utah uSA 
&&ground Lrpoprotein llpase (LPLJ plays a cenlral rola m lipfd metabolism. 
hydmtyzmg tnglycende in chylomrcrons anu VLDL. Common polymorphc 
vanants of the LPL gene have recently been rdentltkzd. Those defmed by 
the Hrcdili and pvull restnctron sttes may alter plasma ltptds. We @sW 
whether the* LPL potymorpttphimrs - wtrcaw. the ten common%llde(-J 
or the homozygous genotype (--I-) - mtght be PrediCtOfS Ot InCTeaSd n9k 
tw -2ry artery tttsease (CAD) and mywrdral &KZF~K~? (f&J. 
Metnods: Blood was drawn tmm 1067 Conseclnhre corIsemlng Pt un. 
dergotng coronary angmgraphv Segments contammg Ihc site ln lntmn 8 (“1 
I 067) and the site m mhon 6 (nt 685) were ampllticd by the potV6nsc Cha’n 
reactton and dIgested. Polymorphrsms Were ldentltied aner el~~~s’s 
m t .5?!, agamse gel and staining with ethidium bmm@e. 
&su!B: Frequencres ot the (-) allele were 41.9’&. 43.690 for ml end 
27.30~. 27.496 for ~;ndJll in non-GAD (C 10% stenosrs) and non-MI ContrOts. 
respectively. Genotype distributions conformed to Hardy-Wernkrg ema. 
lions; connob homomte (-I-) genotype frequencies were 18.3X 179”. 
jn the 2 ccntrofll groups. re+ily. For Pwull. the homozygote (-‘-J tm- 
quency was not imaged for MI (23.490. OR = 1.4. P = 0.1) Or CAD Pt 
(,609$ StenOsrs) (21 .po. OR = 1.17). overall or m men. However. the (-‘- 1 
oenome was increased (30~ LS is”&. OR -7 2.8. p . 0.008) In women wth 
MI us controls. For HindIll, lho homorygola (~ 1” ) froquonoy 0160 wns nal 
inorensod In MI (0.7% OR _ 1 ,l) cr CAD pl (8.31, OR 9 O.fS). 
Conclusron: Common LPL polvmarphmma nro not nssoclntod wcth lnrgo 
lncreasos tn nsk (OR 1 1,s) for CAD or MI. Howovor, smallor ovemll risk. 
or rxlbgroup apoc~kc nskR (~a, In woman), nro nal excluded. nnd should bo 
furlher avnlunlad. 
P, Rodrlgu@8, M, do Lurdaa Andmda, .I. Coucele, J. Amvodo, M,I, Porelrn. 
I, Arrojn, T. Vax, I. Oil, 0, Sl\vn, 8, lXmr\a, V. Amu)o, L. Guermmx M dn 
Grnqn Marnln, 00~ E!&?qulmlca, Fat QOnclns Mddkm, Unh! Now? do 
LMKM, Slsrvl~as Cnfdinlq~gln, 0 EnnrlacrhNagrn, Mmp “Ep3.q Manir: 
LWm, Canfro do Cflordralo~fn do PhrIwilo, tb.sp f%rlmrrTtb Fhrftf~nl 
The rolnllanahlp bnlwoon nlhorognnanla nnd lhrombagonc~slri IA wall oslnb, 
llahod and wldnly roconnlrod. Tho plnsmn loval al Ilpoprolain (n) - Lp(a) . 
hnl w dlrecl lnvolvomanl an lha pnlhophyalullrgy al coronnry orlary dlaonso 
(CAD). lhmuah 118 dunl mlo OR n lrnn8porl nnd lnlorncllon pnrlcclo an lhn 
andolhallnl wall. Wo as#umo lhnl lha hlghor tha plnnmn lavol ol Lp(o) nnd 
amnllar lhs moloculnr shucluro ol npoprololn (n) . Ape (a), more aoatly Cp(n) 
cnn axpmsla IIR pnthaQania atlaot. IAO Lp(a) wnn avnktdnd III a papulnhon al 
43 pin wllh cllnlcnl dlo6nnnls ol CAD, maan ago 7hR 1 II yta (!iB-HI yes), 40% 
mnlw gondor. dlvldod nccardlng lo lnoronwng dogroan at CCS clnstxltanhon 
snd thapmnnnco olocalo myocnrdiol Inlnmllon (AMI) Alhomllonlc lp(o) VW 
Idbnllflad, gsnollcnlly dobxmlnod wilh aavaral I8omorphlc fatma - lso Lp(n) 
. whloh warn dallnad m tormn 01 lho mimbor ol knnglos. I8olp(a) can bo 
dlvlded In lwa groupw, dopandlng on ila dlmanslona nnd ponolrnbng co+xl!y 
01 lhn ondalhelinl wnll. laoLp(n) wllh rmnll dlmonslona (Qroup I; n a 20 pls) 
. IloLp(a) p, B, 81 nnd S2. mpmsonl Iho parllclaa wtlh highor ponolraling 
CapnClly ‘n mu &xlnl wnll. whllo tha laoLp(n) wllh gronlor dlmonstons and 
IawQr pnnolmling cnpnclly . laoLp(o) S3. SO nnd S 4 . wow included In 
the rocond (amup (Qroup II: n m 23 pla). laoLp(n) nm doloclod by spocd~c 
and highly Roloc1lvo blochomlcnl tochnlqua lollawod by tmrnunoblo~llng and 
nnzymallc dofacllon Totnl Choloshxol (Chol), LP rich In Chol (LDL. HDL. 
HDl-2). Lp(a) nnd nn~l.phosphollpld nn\l.bodias (APA) warn do\ormmod. 
Tho Isomorphic spoclas In c~rculnhng Lp(n) wllh small dlmensmns h~vo 
a htighor nlhorogorvc polonhnl IhOl IS cllroclly rolnlod wllh 11s ponolralmg 
cnpnclty nnd nccurnulnllon wllhm Iho nrl@nal wnll. Paltenls wllh more sovero 
clinical oxpross~on 01 CAD hnvo mom lroqucnt small Isomorphtc Apo (a) 
and lhls could have palho-physlologtc Impllcaltons m lho progrosslon and 
growing ot Inlra-coronnry nlharomdous los1ons 
1065-14 Human Qaraoxwase (PONA) Qenotype 
Determlnes the Susceptlblllty to Oxldatlon of 
High-Density Llpoproteln (HDL) Particle 
Y. Walnnnbo. H. Ohmurn. M. Snwano. Ii Mokuno. Ii Daida. Ii Yamaguchl. 
Junfendo Ufl~vrrs~fy Tbkyo, Japan 
t3ackground~ PONA IS a HDL nssoclaled enzyme thal hydrolyze organphos- 
phales. carboxyllc acids osler. and carbamnlo. Recently the assoclallon 01 
coronary attory dlsonse (CAD) and PONA achvlty woro reported. and PONA 
genolype IS consldemd as a new coronary nsk factor. In lhls study we inves- 
hgated lho PONA genotype and suscopllblltly lo ouldallon of kpoprotems lo 
elucidate the contnbulion of PONA to alherosclerosls 
Mefhods: We analyzed 134 pahonls who underwent coronary anglogra- 
phy in our hospllnl. DNA were obtained from patients blood and PCR-RFLP 
methods were used lo determine the GlnlArg polymorphfsm 01 PONA. Gcno- 
type frequency ot AJA, A/B, B/B were 26 9%. 35.1?,. 38.1%. respectively. 
L!poprotelns were obtained lrom pahenls al least 12 hours fastmg and were 
separated with soquontlal ullracenlilugalion. We analyzed TBARS and the 
conhnuous momlonng 01 copper Induced oxidallon using 5 ,iM CuSO4 and 
100 rtg pmleln of each llpoprotems al 37C among the groups of three geno- 
typo. 
&%ulfs: TEARS levels ol plasma. VLDL. nnd LDL did not differ among 
the groups. but HDL TEARS were significantly higher in A/A than A/E or B/B 
(1.013. 0.616. 0.562 nM MDA/mg protein, p = 0.014). In A/A, LDL lag-hme 
was slightly shorter than A/B or 818 (43.2. 46.6. 46.0 min., p = 0.051). also 
HDL lag-lime was significantly shorter than A/B or B/B (16.4, 21.9.20.1 mm., 
P = 0.005) There was no ditference 01 CAD prevalence among the groups 
(A/A = 7S0.. AIE = 74O,. BIB = ES%). 
JACC’ . I;chnl;~n IVOX 
Conckfsion: PONA gonolype clonrly delermmed the axrdnkvo modilicnlton 
al HDL pnnlclo. Although wa lnllad IQ conlirm the assooielion of PONA germ 
lypo nnd CAD In the prosonl oludy, PONA mny plny a role In pnthogenasls 
al nlharosclarosir via HDL oxidnlion, 
11065-l 5 1 Llpoproteln Llpato Qens Polymorphbm8: 
Asroclatlone With Coronary Artery Dltwaso and 
Llpoproteln l.svel@~ In Japnna$c Populntlon 
M. Snwnna, Y. Wntnnnba. H. Ohmum. K. Shimadn. Il. Mokuna, H. Pnlda, 
l-l. Ynmnguoh13 JwWxfa Uniwarfy Tolip& &Ipan 
&dgmun@ In twmo provim~s ahidies, sevsrnl rosttickon fmgmenl longlh 
polymorphisms (RFLP8) in Iba lrpopmloin kpnsa (LPI.) gene were nrrsocialod 
wilh camnnry adory disenno (GAD) and plasma lIpid lavsk Rut it 18 bsa 
clonrty nslbkahed in Jopnnbso populaban. In thi8 r&!dy, we QUamiM?d Ihe 
dis~nbullon al the LPI. palymorphiams in a Jnpnneso population and the 
nnaocinllons bslwuen cl% polymorphisms (Hind III. Pvrr II) and CAD, plasma 
llpld lovols 
&fof))od? All pnlconle (n a 209, IOn males) wore undorwonl coronary 
nngiogmphy. CAD+ was dolmcd as .Sll% solnosts in nl @sl one ot mayor 
branch ot cnronnry nrlory (CAR+ = 146) Tho Hmd lll/Fvu II genotypas were 
nnnlyrod by 17CR RFLPa. 
Ff&sitlb’ Tho tmqwwioa PI Iho II2 and P2 alleles (“2” dcnolos presence 
ol cutlmg RIIQ) wore O.BO nnd 0.713. raspeclivo~y. Tha H2HP gwotypo was 
wgnilicnnlly more tmquonl in CAD+ lhan CAD (P . 001). The & II 
polymorphism showod no signikcan~ nssociallons wllh CAD H2H2 genotVpo 
nsaocinlod wilh slgnilicnn~ly lower levels ot HDL (P . 0.05) and Ape Al (P . 
0.05) thnn HlH2 + HlHl gonalypo. (43 t 16varsus 50 L 21 m@ll [mean 1 
SOl and lt2 i 23 vorw I22 t 2G mgtdl, respochvely). P2P2 geno~pe had 
nlso signileanlly lowor levels 01 HOL (P . 0.05) and Apo Al (P . 0.01) lhan 
PlP2tP2P2 gonolypo (43 t 1G versus 50 t 20 mgfdl and 112 t 22 velsus 
123 t 26 mgfdl, mspockvaly). Them were no other ass~~almns belween 
LPL RFlPs and olher kpoprolocn cumponenls 
Conclusrona- Tho rosulls ~uggoal lhal Hmd 111 polymorphism m the lP1 
gono contnbulos lo HDL cholostoml lovols and devclopmenl ol CAD 
( 1065-l 6 1 Recombinant Apollpoproteln A-Iuilam Protects 
Agalnst Lysophosphatldylcholine-induced 
Endothellal Dyafuncllon 
B.0 Coin. P.K. Shah, J. Yano. M.D. Molloy. B Cercek. S Kaul 
Cedars-Star A9ed1cal Centor. lm Angeles. CA. USA 
We pmvtously demonshaled anllalherogenlc effects 01 reconsllluled htgh 
dens@ kpoprole~n IHDL) usmg Iho recombmanl apokpoprotem (ape) A-l mu- 
lnnl. ap~A.lu,~,~~, (ApoM). complexed with the phosphokpld tamer DMPC In 
lhls study. we examined whelhcr ApoM has any ellecls on lysophosphalldyl- 
cholmo (LPQ~mduced lmpalrmcnl 01 endothekum-dependent vasodllalalmn 
Rosponses lo acelylcholmo (1 rlM) were oxammed m camlld arlenes lmm 
15 normal rabbIIs perlused in uctro belorc and aker mcubalion wllh LPC (50 
JIM) m absence and presence 01 apoM and wlld.lype ape A-l (ApoWT) cam- 
ploxcd wilh DMPC. plasma-donved HDL. free apoM (F-ApoM) (all 1 mgfml) 
and Iho carnor DMPC (30 rtgjml). Changes m dlameler were measured. 
and responses were oxpressed as % change m ckameter (mean t SD) of 
proconslricled arlenes. Basellne dlamcler 01 carotid arlenes was 2.9 t 0 1 
mm. ‘p I 0.05 vorsus.LPC control. 
LFC 
Canlrol 
63 ! 7 
APOM ApoWl 
60 * ,‘I 76 I 16 
HDL 
75 I II 
FAopM 
i7 : 22 
DMPC 
81 1 22 
l LPC 29 t 21’ 56 22 J6 : 26 36 ! 35 22 * 2’ 24 : 25’ 
N 9 9 6 5 5 5 
LPC had no ellects on sodium mlroprusslde-mediated vasodllalahon. 
Conc/usron- Apo A-lk,,,a”O and apo A-l wild-type-reconsh~uled HDL as well 
as plasma-derived HDL. but not free apoM or the earner DMPC. slgmlicantly 
allonuatcd LPC-induced lmpalrment of endothekum-dependent vasodllala- 
11on. The proleclwe effects of apoM and apoWT were more pronounced than 
plasma HDL. Thus, reversal 01 endothellal dysfuncllon by HDL may. in part. 
explain the Inverse relatlonshlp between HDL choleslerol and coronary heart 
disease. 
1065-l 7 Famlllal Hypercholesterolemla: The Limited 
Predictive Value of Plasma LDL-Cholesterol 
M.A W. Humans-Eckenhausen' . J.C. Defesche*. J.J.P. Kastelein?. ‘The 
StOEH. The Netherlands: ‘The Academic Medical Certfer. Amsterdam. The 
Netherlands 
Background: Demonslratlon of a mutation in the LDL-receptor gene conhrms 
